News

This is the second milestone reached in the three-year collaboration initially announced in January 2006. In the collaboration, BioFocus DPI applied its SilenceSelect shRNA-based gene collection to run

The patent contains claims that cover orally administrable compositions comprising Collegium’s proprietary micro-particle formulations. The formulations are designed to be more resistant to physical methods of tampering than

This patent will specifically protect Cytori’s Celution System-based devices and methods essential in novel cosmetic and reconstructive surgery procedures. According to Cytori, this is an important development for

The downsizing of the sales force started with Wyeth, which announced a lay off of 1,200 sales personnel in March, 2008. Later, in April, Johnson & Johnson announced

This Phase II study is designed to assess the safety, tolerability and efficacy of four transscleral iontophoretic doses of EGP-437, a proprietary formulation of a well studied corticosteroid,

In addition, Lev shareholders will receive the non-transferrable contractual right to two contingent payments of $0.50 each that could deliver up to an additional $174.6 million, or $1

As a condition for the exclusive negotiation rights, Dompe entered into a securities sale agreement with Dyax to purchase two million shares of Dyax common stock in a

Medicago has obtained a grant from the Quebec Ministry of Economic Development, Innovation and Export Trade to finance 40% of the study. The study will be conducted by

TraumaCad is expected to be integrated with other existing systems at Duke and will ultimately enable surgeons to have single-click access to TraumaCad. Zeev Glozman, founder and CEO